The title compound, C 13 H 16 N 10 O 5 S (systematic name: 1-(4,6-dimethoxypyrimidin-2-yl)-3-{[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-yl]sulfonyl}urea), is a second triclinic polymorph of this crystal [for the other, see: Jeon et al., (2015) . Acta Cryst. E71, o470-o471]. There are two molecules, A and B, in the asymmetric unit; the dihedral angles between the pyrazole ring and the tetrazole and dimethoxypyrimidine ring planes are 72.84 (10) and 37.24 (14) , respectively (molecule A) and 84.38 (9) and 26.09 (15) , respectively (molecule B). Each molecule features an intramolecular N-HÁ Á ÁN hydrogen bond. In the crystal, aromatic -stacking interactions [centroid-centroid separations = 3.9871 (16), 3.4487 (14) and 3.5455 (16) Å ] link the molecules into [001] chains. In addition, N-HÁ Á ÁN, N-HÁ Á ÁO, C-HÁ Á ÁO and C-HÁ Á ÁN hydrogen bonds occur, forming a three-dimensional architecture. We propose that the dimorphism results from differences in conformations and packing owing to different intermolecular interactions, especially aromatic -stacking.
Chemical context
Sulfonylurea herbicides are well known as being highly beneficial for controlling undesirable vegetation in agronomically desirable crops including corn and cereals such as wheat and barley. Azimsulfuron is a recently introduced highly selective sulfonylurea herbicide (Valle et al., 2006) and has been found to be particularly useful as a post-emergent herbicide for weed control in rice paddies and suppression of barnyard grass in rice (Venkatesh et al., 2016) . The crystal structure of azimsulfuron (dimorph I) has already been reported in our previous study (Jeon et al., 2015) . We now report the crystal structure of a second triclinic polymorph, grown under different conditions, as observed for other systems (Schmidt & Jansen, 2012; Ebenezer & Muthiah, 2010) . ISSN 2056-9890 
Structural commentary
The asymmetric unit of the new dimorph II (Fig. 1) , consists of two independent molecules, A and B, which are curved and form a 'boxing glove' shape around the pyrazole ring. The dihedral angles between the pyrazole ring and the tetrazole and dimethoxypyrimidine ring planes are 72.84 (10) and 37.24 (14) , respectively, in molecule A and 84.38 (9) and 26. 09 (15) , respectively, in molecule B. All bond lengths and bond angles are normal and comparable to those observed in similar crystal structures (Chopra et al., 2004; Kwon et al., 2015) . Each molecule features an intramolecular N-HÁ Á ÁN hydrogen bond (Table 1) , which closes an S(6) ring.
Supramolecular features
In the crystal, aromatic -stacking interactions, Cg1Á Á ÁCg1 iii = 3.9817 (16), Cg3Á Á ÁCg6 vii = 3.4487 (14) and Cg4Á Á ÁCg4 viii = 3.5455 (16) Å occur [Cg1, Cg3, Cg4 and Cg6 are the centroids of the N5/N6/C8-C10, N1/N2/C2-C5, N15/N16/C21-C23 and N11/N12/C15-C18 rings, respectively; symmetry codes: (vii) x, y, z, (viii) Àx + 2, Ày, Àz + 2]. Together, these link adjacent molecules, forming chains propagating along the c axis. (Fig. 2) . In addition, there are N-HÁ Á ÁN, N-HÁ Á ÁO, C-HÁ Á ÁO and C-HÁ Á ÁN hydrogen bonds in dimorph II (Table 1) , which generate a three-dimensional architecture. The asymmetric unit of the title compound, with displacement ellipsoids drawn at the 50% probability level. H atoms are shown as small spheres of arbitrary radius. Table 1 Hydrogen-bond geometry (Å ,  ) . 
Figure 2
The crystal packing, viewed along the b axis. H atoms have been omitted for clarity.
The previous dimorph has only one -interaction between the tetrazole rings of neighboring molecules, while the present dimorph has three -interactions between dimethoxypyrimidine rings in the asymmetric unit, and between the pyrazole rings of neighboring A or B molecules.
Synthesis and crystallization
In the previous report, crystals were obtained by using CH 3 CN solvent, whereas colourless needles of the title polymorph were prepared by slow evaporation of a methanol solution.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . All H atoms were positioned geometrically and refined using a riding model with d(N-H) = 0.88 Å , U iso = 1.2U eq (C) for N-H groups, d(C-H) = 0.88 Å , U iso = 1.2U eq (C) for Csp Computer programs: APEX2 and SAINT (Bruker, 2014) , SHELXS97 and SHELXTL (Sheldrick, 2008) , SHELXL2014 (Sheldrick, 2015) , DIAMOND (Brandenburg, 2010) and publCIF (Westrip, 2010 
Computing details
Data collection: APEX2 (Bruker, 2014 ); cell refinement: SAINT (Bruker, 2014) ; data reduction: SAINT (Bruker, 2014 );
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015) ; molecular graphics: DIAMOND (Brandenburg, 2010) ; software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and publCIF (Westrip, 2010) .
1-(4,6-Dimethoxypyrimidin-2-yl)-3-{[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-yl]sulfonyl}urea
Crystal data 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
